Spyre Therapeutics, Inc.
For the period ended Apr 13, 2026. Filed Apr 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 13, 2026 · Filed Apr 13, 2026
Use the contents to explore the available documents and sections.
SYRE$103.86+7.5%Stored close · as of Nov 6, 2026
Opening this filing…